Literature DB >> 30825183

Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.

Simin Ahmadvand1,2, Zahra Faghih2, Mehdi Montazer3, Akbar Safaei3, Maral Mokhtari3, Peyman Jafari4, Abdol-Rasoul Talei5, Sedigheh Tahmasebi5, Abbas Ghaderi6,7.   

Abstract

PURPOSE: In recent years, the prognostic/predictive significance of tumor infiltrating lymphocytes (TILs) has become a topic of interest. Here, we aimed to evaluate the prognostic significance of CD3+, CD8+, CD45RO+ and Foxp3+ TILs in breast cancer, as well as the relation of these markers to other clinicopathological features of this disease.
METHODS: FFPE tumor samples from 94 females with invasive ductal carcinoma of the breast were retrospectively selected and immunohistochemically assessed for CD3, CD8, CD45RO and Foxp3 expression. Digital photos were acquired from the center (CT) and invasive margins (IM) of the tumors, after which positive cells were counted using ImageJ software.
RESULTS: We found that greater infiltrations of target lymphocyte subpopulations were associated with TNM stage III, lymph node metastasis, high histological grade, ER negativity and HER2 positivity. The ratios of CD8+ cytotoxic T cells to CD3+, CD45RO+ and Foxp3+ TILs were found to be relatively higher in tumors exhibiting the aforementioned characteristics. In univariate survival analyses, CD8+ TILs in the IM and total CD45RO+ TILs were found to be significantly associated with overall survival (OS). Infiltration of CD45RO+ TILs in the CT and lymph node status were variables that significantly correlated with disease-free survival (DFS). Multiple Cox regression analyses revealed independent significant prognostic effects of total CD45RO+ TILs and lymph node status (HR of 3.24 and 3.19, respectively) in predicting OS. Infiltration of CD45RO+ TILs in the CT (HR 3.12) and lymph node status (HR 3.15) also exhibited significant prognostic effects on DFS.
CONCLUSION: From our data we conclude that CD45RO+ TILs serve as prognostic factors for predicting OS and DFS of breast cancer patients.

Entities:  

Keywords:  Breast cancer; CD45RO+ memory T cell; CD8+ cytotoxic T cell; Prognostic marker; Tumor-infiltrating lymphocytes

Mesh:

Substances:

Year:  2019        PMID: 30825183     DOI: 10.1007/s13402-019-00430-6

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  12 in total

1.  The Prognostic and Predictive Significance of Tumor-Infiltrating Memory T Cells Is Reversed in High-Risk HNSCC.

Authors:  Rebekka Hartan; Sören Schnellhardt; Maike Büttner-Herold; Christoph Daniel; Arndt Hartmann; Rainer Fietkau; Luitpold Distel
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

2.  Biological interpretation of prognostic radiomic score by correlating with tumor heterogeneity and microenvironment.

Authors:  Jieling Zheng; Bin Zhang
Journal:  Breast Cancer Res       Date:  2022-05-09       Impact factor: 8.408

3.  [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].

Authors:  Qifan Tan; Haoyang Li; Mengjun Yu; Xiaonan Tang; Jinjing Tan; Shucai Zhang; Jinghui Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-04-20

4.  An Efficient Prognostic Immune Scoring System For Colorectal Cancer Patients With Peritoneal Metastasis.

Authors:  Yamei Zhao; Chao Chen; Xiaoming Xu; Xiaoxu Ge; Kefeng Ding; Shu Zheng; Jian Wang; Lifeng Sun
Journal:  Oncoimmunology       Date:  2021-03-22       Impact factor: 8.110

5.  Lipid Droplet-Related PLIN2 in CD68+ Tumor-Associated Macrophage of Oral Squamous Cell Carcinoma: Implications for Cancer Prognosis and Immunotherapy.

Authors:  Yijia He; Yuexin Dong; Xinwen Zhang; Zhuang Ding; Yuxian Song; Xiaofeng Huang; Sheng Chen; Zhiyong Wang; Yanhong Ni; Liang Ding
Journal:  Front Oncol       Date:  2022-03-15       Impact factor: 6.244

Review 6.  Stromal and Immune Cell Dynamics in Tumor Associated Tertiary Lymphoid Structures and Anti-Tumor Immune Responses.

Authors:  Alessandra Rossi; Beatrice Belmonte; Silvia Carnevale; Antonietta Liotti; Veronica De Rosa; Sebastien Jaillon; Silvia Piconese; Claudio Tripodo
Journal:  Front Cell Dev Biol       Date:  2022-07-08

7.  Pulsed focused ultrasound can improve the anti-cancer effects of immune checkpoint inhibitors in murine pancreatic cancer.

Authors:  Petros X E Mouratidis; Marcia Costa; Ian Rivens; Elizabeth E Repasky; Gail Ter Haar
Journal:  J R Soc Interface       Date:  2021-07-07       Impact factor: 4.118

8.  CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer.

Authors:  Yasmin Vahidi; Mandana Bagheri; Abbas Ghaderi; Zahra Faghih
Journal:  BMC Cancer       Date:  2020-03-30       Impact factor: 4.430

9.  Tumour-Infiltrating Inflammatory Cells in Early Breast Cancer: An Underrated Prognostic and Predictive Factor?

Authors:  Sören Schnellhardt; Ramona Erber; Maike Büttner-Herold; Marie-Charlotte Rosahl; Oliver J Ott; Vratislav Strnad; Matthias W Beckmann; Lillian King; Arndt Hartmann; Rainer Fietkau; Luitpold Distel
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

10.  4H12, a Murine Monoclonal Antibody Directed against Myosin Heavy Chain-9 Expressed on Acinar Cell Carcinoma of Pancreas with Potential Therapeutic Application

Authors:  Sima Balouchi-Anaraki; Simin Ahmadvand; Akbar Safaei; Abbas Ghaderi
Journal:  Iran Biomed J       Date:  2021-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.